BOPW
FOLD

Brandywine Oak Private Wealth’s Amicus Therapeutics FOLD Stock Holding History

Brandywine Oak Private Wealth’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-14,676
Closed -$142K – 234
2019
Q4 		$142K Buy
+14,676
New +$134K 0.03% 236
2019
Q1 		– Sell
-11,304
Closed -$110K – 356
2018
Q4 		$110K Buy
+11,304
New +$124K 0.02% 262

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Brandywine Oak Private Wealth's FOLD Position: Q1 2020 in Review

Brandywine Oak Private Wealth sold out of Amicus Therapeutics (FOLD) in Q1 2020, closing a stake of 14,676 shares — an estimated $142K sold.

Brandywine Oak Private Wealth first reported a position in FOLD in Q4 2018 and held it in 2 quarters. The position peaked at $142K in Q4 2019. 203 funds tracked by Wall St. Rank hold FOLD as of Q1 2020.

  • Brandywine Oak Private Wealth reported no remaining Amicus Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Brandywine Oak Private Wealth sold 14,676 Amicus Therapeutics shares in Q1 2020, an estimated $142K.
  • Brandywine Oak Private Wealth first reported a position in Amicus Therapeutics in Q4 2018 and held it in 2 quarters.
  • Brandywine Oak Private Wealth's Amicus Therapeutics position peaked at $142K in Q4 2019.
  • 203 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2020.

Based on Brandywine Oak Private Wealth's 13F filing for Q1 2020, filed 6 May 2020.